Regeneron Pharmaceuticals (REGN.VI) Q3 2024 Earnings

Aug 1Confirmed
Q4 2023
Q1 2024
Q2 2024
Q3 2024
8.9
9.6
10.3
10.99

Details

Expected EPS
9.83993772025
Actual EPS
10.71323
Surprise EPS
0.87
Surprise Percent
+8.87%

Description

⁨Regeneron Pharmaceuticals⁩ (⁦REGN.VI⁩) has reported earnings of ⁦10.71323⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts